$7.84
0.26[3.43%]
At close: May 10
$7.84
0[0.00%]
PreMarket: 5:34PM EDT
Outlook Therapeutics
(NASDAQ:OTLK)Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 58.000 / 652.076K |
| Day Range | - - - |
| 52 Wk Range | 4.004 - 40.600 |
| Market Cap | $182.660M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 5.78% |
| Days to Cover | 2.07 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by BTIG on Wednesday, March 27, 2024. The analyst firm set a price target for 50.00 expecting OTLK to rise to within 12 months (a possible 537.76% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $7.84 last updated May 10, 2024 at 5:34 PM EDT.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q3 earnings are confirmed for Monday, August 12, 2024.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.